Trial Profile
Reduction in hepatitis B virus load and its correlation with Th1/Th2 immunity in patients with chronic hepatitis B during long-term treatment with entecavir.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 23 Dec 2015 New trial record